Piramal Pharma Limited — Others, 06-12-2024: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Piramal Pharma Solutions Inc., a wholly owned subsidiary, has settled a civil suit with VetDC, Inc. for USD 407,400 regarding product liability claims. While the company asserts its defensive stance against VetDC's allegations, the settlement aims to avoid ongoing legal costs and uncertainties. Importantly, this settlement is not expected to significantly affect Piramal Pharma's financial health. The resolution of this litigation could alleviate some risk and uncertainty for investors, potentially fostering a more stable outlook for the company’s operations moving forward.